Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hosking

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Scientific Reports|February 18, 2018
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary FibrosisK Griffiths, D M Habiel, J Jaffar, et al.
Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.
Plos Neglected Tropical Diseases|December 20, 2015
Generation of a Novel Bacteriophage Library Displaying scFv Antibody Fragments from the Natural Buffalo Host to Identify Antigens from Adult Schistosoma japonicum for Diagnostic DevelopmentChristopher G Hosking, Hamish E G McWilliam, Patrick Driguez, et al.
International Journal for Parasitology|June 28, 2015
Using the local immune response from the natural buffalo host to generate an antibody fragment library that binds the early larval stages of Schistosoma japonicumChristopher G Hosking, Patrick Driguez, Hamish E G McWilliam, et al.
JCI Insight|January 11, 2022
A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4Qinghua Cao, Chunling Huang, Hao Yi, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Scientific Reports|February 18, 2018
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary FibrosisK Griffiths, D M Habiel, J Jaffar, et al.
Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.
Plos Neglected Tropical Diseases|December 20, 2015
Generation of a Novel Bacteriophage Library Displaying scFv Antibody Fragments from the Natural Buffalo Host to Identify Antigens from Adult Schistosoma japonicum for Diagnostic DevelopmentChristopher G Hosking, Hamish E G McWilliam, Patrick Driguez, et al.
International Journal for Parasitology|June 28, 2015
Using the local immune response from the natural buffalo host to generate an antibody fragment library that binds the early larval stages of Schistosoma japonicumChristopher G Hosking, Patrick Driguez, Hamish E G McWilliam, et al.
JCI Insight|January 11, 2022
A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4Qinghua Cao, Chunling Huang, Hao Yi, et al.
Pageof 8